
Orasis Pharmaceuticals
Operator of an ophthalmic pharmaceutical company intended to develop corrective eye drops for the treatment of presbyopia. The company's eye drop improves near-uncorrected visual acuity and relieves p...
Valuation
$0
Share Price
N/A
Total Raised
$130.5M
Last Round
N/A